Regulatory status record

Is Oxytocin banned in India?

Last checked 1 October 2026

Oxytocin. Status: Restricted (2018 order).

Oxytocin is not banned in India as of 1 Oct 2026; a 2018 Gazette order restricting its manufacture to a public-sector supplier and barring retail sale was challenged in the Delhi High Court and Supreme Court; the outcome is unverified.

Classification
Restricted under Section 26A, Drugs and Cosmetics Act, 1940
Decided by
CDSCO / Ministry of Health and Family Welfare; Delhi High Court; Supreme Court of India
Reference
GSR notification, 2018, under Section 26A; court orders 2018 to 2019
Evidence
Government document
Latest action
27 April 2018
Last checked
1 October 2026

Oxytocin given by intravenous infusion. Photo: Intravenous therapy oxcytocin.jpg by Eliran t (CC BY-SA 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.

Primary government sourceTier 1: government primary source

CDSCO: Drugs banned in India (consumer section)

CDSCO / Ministry of Health and Family Welfare; Delhi High Court; Supreme Court of India · GSR notification, 2018, under Section 26A; court orders 2018 to 2019

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Governing authority
CDSCO, Ministry of Health and Family Welfare
2018 order
Manufacture for domestic use confined to Karnataka Antibiotics & Pharmaceuticals (public sector); retail sale barred
Reason
Misuse in dairy cattle and vegetables; illegal manufacture
Litigation
Delhi HC and Supreme Court, 2018 to 2019, later position not published
Clinical use
Essential medicine for post-partum haemorrhage; supplied to hospitals

Oxytocin is the hormone injection used to induce labour and to stop bleeding after childbirth. It is on the WHO's list of essential medicines, and it is also one of the most misused drugs in India, injected into dairy cattle to force milk let-down and into vegetables to make them swell.

In 2018 the Health Ministry used Section 26A to restrict, rather than ban, the drug. The Gazette order confined manufacture of oxytocin for domestic use to a single public-sector company, Karnataka Antibiotics & Pharmaceuticals, barred its sale by retail chemists and required supply to go directly to hospitals and clinics. Private manufacturers and hospital associations challenged the order in the Delhi High Court, arguing that a single supplier risked shortages in obstetric emergencies, and the matter went on to the Supreme Court. The Delhi High Court set the order aside in December 2018 and the government appealed to the Supreme Court; the final outcome has not been published. This page therefore describes oxytocin as restricted, not banned.

What is not in doubt is the clinical position. Oxytocin remains the standard treatment for post-partum haemorrhage, and hospitals have continued to receive it throughout the litigation. Any oxytocin sold to the public, and any used on animals or produce, is illegal whatever the outcome of the court case.

What this means for you

Hospitals continue to use it

Oxytocin remains a WHO essential medicine for childbirth; the restriction concerns who may make and sell it, not whether doctors may use it.

It should not be available over the counter

Retail sale was barred by the 2018 order; any oxytocin sold to the public, or for cattle, is illegal.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Ingredient records

Every banned combination and failed batch containing each ingredient.

Batches declared Not of Standard Quality

Batches of products containing Oxytocin flagged in CDSCO monthly alerts. An NSQ result concerns one batch, not the molecule or the brand.

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Oxytocin Injection IP Batch IA26-64Mfg Jan 2026 · Exp Dec 2027 Om Biomedic Pvt. LtdUttarakhand The sample does not comply I.P. 2022 with respect to the test for "Bacterial Endotoxins and Sterility" of Oxytocin Injections.Sterility RDTL, GuwahatiCDSCO lab Sep 2026
Oxytocin Injection I.P. Batch 91707Mfg Jun 2026 · Exp May 2028 Neon Laboratories LtdMaharashtra Assay of Oxytocin I.P.Assay SFDTL, UttarakhandState lab Aug 2026
Oxytocin Injection IP 5IU/ml, Batch I-7881Mfg Nov 2025 · Exp Oct 2027 Jackson Laboratories Pvt.Ltd 22-24Punjab The sample failed in Identification test of OxytocinIdentification DTL, DelhiState lab Jul 2026
Oxytocin Injection IP 5IU/ml Batch I-7881Mfg Nov 2025 · Exp Oct 2027 Jackson Laboratories Pvt. LtdPunjab The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Particulate MatterIdentification RDTL, ChandigarhCDSCO lab Jul 2026
Oxytocin Injection IP 5 IU/ml Batch I-7881Mfg Nov 2025 · Exp Oct 2027 Jackson Laboratories Pvt. LtdPunjab The sample does not conform to the IP as it does not contain Oxytocin (Synthetic) Nil.Other DTL, JaipurState lab May 2026
Oxytocin Injection (Vet.) Batch 04Mfg Dec 2024 · Exp Nov 2027 Super Vaishali LaboratoriesBihar The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act 1940 with respect to test for Particulate matter and Description.Description CDL, KolkataCDSCO lab Jan 2026
Oxytocin Injection IP Batch OR2OX-01Mfg Dec 2024 · Exp Nov 2026 Biomedica Laboratories LtdMadhya Pradesh Assay of OxytocinAssay DTL, JaipurState lab Aug 2025
Oxytocin Injection I.P. 1ml Batch AOX-2402Mfg Apr 2024 · Exp Mar 2026 Systochem Laboratories Ltd Assay of OxytocinAssay CDL KolkataCDSCO lab Jun 2025
Injection Oxytocin Vet. 50 ml Vial Batch Not applicableMfg ? · Exp ? Not applicable pH and SterilitySterility RDTL, ChandigarhCDSCO lab May 2025
Injection Oxytocin Vet. 100 ml Vial Batch Not applicableMfg ? · Exp ? Not applicable pH and SterilitySterility RDTL, ChandigarhCDSCO lab May 2025
Oxytocin Injection I.P. 5 IU/1 ml Batch OTC-382AMfg Apr 2023 · Exp Mar 2025 Pushkar PharmaHimachal Pradesh Description, Particulate matter & Assay of OxytocinAssay CDL KolkataCDSCO lab Sep 2024
Oxytocin Injection I.P. 1 ml Batch 22X23002Mfg Jul 2023 · Exp Jun 2027 Radiant Parenterals LtdGujarat AssayAssay CDL KolkataCDSCO lab Sep 2024
VETERINARY INJECTION IP VET. (5 OXYTOCIN UNITS/ML, 0.5 W/V CHLORBUTOL PHENOL IP Batch 1Mfg Feb 2021 · Exp Jan 2023 Neelam Chemical WorksWest Bengal Particulate matter, Sterility and the Assay of Oxytocin ActivityAssay RDTL ChandigarhState lab Mar 2022
OXYTOCIN INJECTION IP (VET) 10 OXYTOCIN UNIT PER ML, 0.5% W/V PHENOL IP Batch Not applicableMfg ? · Exp ? Super VaishaliBihar Particulate matter, Sterility and the Assay of Oxytocin ActivityAssay RDTL ChandigarhState lab Mar 2022
OXYTOCIN INJECTION (VET) OXYTOCIN 5 IU/ML, 0.5% W/V PHENOL OR CHLOROBUTOL IP Batch 4Mfg Jan 2022 · Exp Dec 2024 Super Vaishali LaboratoriesBihar Particulate matter, Sterility and the Assay of Oxytocin ActivityAssay RDTL ChandigarhState lab Mar 2022
Showing 15 of 21 records

Sources